{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:50:11Z","timestamp":1783698611141,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1124\/jpet.108.145128","type":"journal-article","created":{"date-parts":[[2008,12,6]],"date-time":"2008-12-06T02:10:01Z","timestamp":1228529401000},"page":"749-757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Neutralizing Anti-Vascular Endothelial Growth Factor (VEGF) Antibody Reduces Severity of Experimental Ulcerative Colitis in Rats: Direct Evidence for the Pathogenic Role of VEGF"],"prefix":"10.1016","volume":"328","author":[{"given":"Ganna","family":"Tolstanova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetyana","family":"Khomenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longchuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Tarnawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Ahluwalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandor","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Sandor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.108.145128_bib1","doi-asserted-by":"crossref","unstructured":"Abreu MT (2002) The pathogenesis of inflammatory bowel disease: translational implications for clinicians. Curr Gastroenterol Rep 4: 481-489.","DOI":"10.1007\/s11894-002-0024-0"},{"key":"10.1124\/jpet.108.145128_bib2","doi-asserted-by":"crossref","unstructured":"Baluk P, Thurston G, Murphy TJ, Bunnett NW, and McDonald DM (1999) Neurogenic plasma leakage in mouse airways. Br J Pharmacol 126: 522-528.","DOI":"10.1038\/sj.bjp.0702323"},{"key":"10.1124\/jpet.108.145128_bib3","doi-asserted-by":"crossref","unstructured":"Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, and Marm\u00e9 D (1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87: 3336-3343.","DOI":"10.1182\/blood.V87.8.3336.bloodjournal8783336"},{"key":"10.1124\/jpet.108.145128_bib4","doi-asserted-by":"crossref","unstructured":"Bousvaros A, Leichtner A, Zurakowski D, Kwon J, Law T, Keough K, and Fishman SJ (1999) Elevated serum vascular endothelial growth factor in children and young adults with Crohn\u2019s disease. Dig Dis Sci 44: 424-430.","DOI":"10.1023\/A:1026635308127"},{"key":"10.1124\/jpet.108.145128_bib5","doi-asserted-by":"crossref","unstructured":"Cane G, Moal VL, Pag\u00e8s G, Servin AL, Hofman P, and Vouret-Craviari V (2007) Up-regulation of intestinal vascular endothelial growth factor by Afa\/Dr diffusely adhering Escherichia coli. PLoS ONE 2: e1359.","DOI":"10.1371\/journal.pone.0001359"},{"key":"10.1124\/jpet.108.145128_bib6","doi-asserted-by":"crossref","unstructured":"Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, et al. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439.","DOI":"10.1038\/380435a0"},{"key":"10.1124\/jpet.108.145128_bib7","doi-asserted-by":"crossref","unstructured":"Carmeliet P (2003) Angiogenesis in health and disease. Nature Med 9: 653-660.","DOI":"10.1038\/nm0603-653"},{"key":"10.1124\/jpet.108.145128_bib8","doi-asserted-by":"crossref","unstructured":"Chidlow JH Jr, Langston W, Greer JJ, Ostanin D, Abdelbaqi M, Houghton J, Senthilkumar A, Shukla D, Mazar AP, Grisham MB, et al. (2006) Differential angiogenic regulation of experimental colitis. Am J Pathol 169: 2014-2030.","DOI":"10.2353\/ajpath.2006.051021"},{"key":"10.1124\/jpet.108.145128_bib9","doi-asserted-by":"crossref","unstructured":"Chou MT, Wang J, and Fujita DJ (2002) Src kinase becomes preferentially associated with the VEGFR, KDR\/Flk-1, following VEGF stimulation of vascular endothelial cells. BMC Biochem 32: 1-11.","DOI":"10.1186\/1471-2091-3-32"},{"key":"10.1124\/jpet.108.145128_bib10","doi-asserted-by":"crossref","unstructured":"Danese S, Sans M, Motte CDL, Graziani C, West G, Phillips MH, Pola R, Rutella S, Willis J, Gasbarrini A, et al. (2006) Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroeneterology 130: 2060-2073.","DOI":"10.1053\/j.gastro.2006.03.054"},{"key":"10.1124\/jpet.108.145128_bib11","doi-asserted-by":"crossref","unstructured":"Di Sabatino A, Ciccocioppo R, Benazzato L, Sturniolo GC, and Corazza GR (2004) Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn\u2019s disease patients. Aliment Pharmacol Ther 19: 1019-1024.","DOI":"10.1111\/j.1365-2036.2004.01927.x"},{"key":"10.1124\/jpet.108.145128_bib12","doi-asserted-by":"crossref","unstructured":"Drake CJ and Little CD (1995) Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. Proc Natl Acad Sci U S A 92: 7657-7661.","DOI":"10.1073\/pnas.92.17.7657"},{"key":"10.1124\/jpet.108.145128_bib13","doi-asserted-by":"crossref","unstructured":"Dvorak HF, Nagy JA, Feng D, Brown LF, and Dvorak AM (1999) Vascular permeability factor\/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 237: 97-132.","DOI":"10.1007\/978-3-642-59953-8_6"},{"key":"10.1124\/jpet.108.145128_bib14","doi-asserted-by":"crossref","unstructured":"Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J, and Cheresh DA (1999) Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 4: 915-924.","DOI":"10.1016\/S1097-2765(00)80221-X"},{"key":"10.1124\/jpet.108.145128_bib15","doi-asserted-by":"crossref","unstructured":"Gavard J and Gutkind JS (2006) VEGF controls endothelial-cell permeability by promoting the \u03b2-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 8: 1223-1234.","DOI":"10.1038\/ncb1486"},{"key":"10.1124\/jpet.108.145128_bib16","doi-asserted-by":"crossref","unstructured":"Goebel S, Huang M, Davis WC, Jennings M, Siahaan TJ, Alexander JS, and Kevil CG (2006) VEGF-A stimulation of leukocyte adhesion to colonic microvascular endothelium: implications for inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 290: G648-G654.","DOI":"10.1152\/ajpgi.00466.2005"},{"key":"10.1124\/jpet.108.145128_bib17","unstructured":"Griga T, May B, Pfisterer O, M\u00fcller KM, and Brasch F (2002) Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with IBD. Hepatogastroenterology 49: 116-123."},{"key":"10.1124\/jpet.108.145128_bib18","doi-asserted-by":"crossref","unstructured":"Griga T, Tromm A, Spranger J, and May B (1998) Increased serum level of vascular endothelial growth factor in patients with inflammatory bowel disease. Scand J Gastroenterol 33: 504-508.","DOI":"10.1080\/00365529850172070"},{"key":"10.1124\/jpet.108.145128_bib19","unstructured":"Griga T, Voigt E, Gretzer B, Brasch F, and May B (1999) Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease. Hepatogastroenterology 46: 920-923."},{"key":"10.1124\/jpet.108.145128_bib20","doi-asserted-by":"crossref","unstructured":"Gupta K, Gupta P, Wild R, Ramakrishnan S, and Hebbel RP (1999) Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: effect on human microvascular endothelial cell proliferation and angiogenesis. Angiogenesis 3: 147-158.","DOI":"10.1023\/A:1009018702832"},{"key":"10.1124\/jpet.108.145128_bib21","doi-asserted-by":"crossref","unstructured":"Hugot JP, Chamaillard M, Zouali H, Lesage S, C\u00e9zard JP, Belaiche J, Almer S, Tysk C, O\u2019Morain CA, Gassull M, et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn\u2019s disease. Nature 411: 599-603.","DOI":"10.1038\/35079107"},{"key":"10.1124\/jpet.108.145128_bib22","doi-asserted-by":"crossref","unstructured":"Kanazawa S, Tsunoda T, Onuma E, Majima T, Kagiyama M, and Kikuchi K (2001) VEGF, basic-FGF, and TGF-\u03b2 in Crohn\u2019s disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am J Gastroenterol 96: 822-828.","DOI":"10.1111\/j.1572-0241.2001.03527.x"},{"key":"10.1124\/jpet.108.145128_bib23","doi-asserted-by":"crossref","unstructured":"Khomenko T, Szabo S, Deng X, Jadus MR, Ishikawa H, Osapay K, Sandor Z, and Chen L (2006) Suppression of early growth response factor-1 with egr-1 antisense oligodeoxynucleotide aggravates experimental duodenal ulcers. Am J Physiol Gastrointest Liver Physiol 290: G1211-G1218.","DOI":"10.1152\/ajpgi.00078.2005"},{"key":"10.1124\/jpet.108.145128_bib24","doi-asserted-by":"crossref","unstructured":"Koch AE, Polverini PJ, and Leibovich JL (1986) Induction of neovascularization by activated human monocytes. J Leukocyt Biol 39: 233-238.","DOI":"10.1002\/jlb.39.2.233"},{"key":"10.1124\/jpet.108.145128_bib25","doi-asserted-by":"crossref","unstructured":"Koutroubakis IE, Tsiolakidou G, Karmiris K, and Kouroumalis EA (2006) Role of angiogenesis in inflammatory bowel disease. Inflamm Bowel Dis 12: 515-523.","DOI":"10.1097\/00054725-200606000-00012"},{"key":"10.1124\/jpet.108.145128_bib26","doi-asserted-by":"crossref","unstructured":"Lodes MJ, Cong Y, Elson CO, Mohamath R, Landers CJ, Targan SR, Fort M, and Hershberg RM (2004) Bacterial fragellin is a dominant antigen in Crohn\u2019s disease. J Clin Invest 113: 1296-1306.","DOI":"10.1172\/JCI200420295"},{"key":"10.1124\/jpet.108.145128_bib27","doi-asserted-by":"crossref","unstructured":"Matsuura M, Okazaki K, Nishio A, Nakase H, Tamaki H, Uchida K, Nishi T, Asada M, Kawasaki K, Fukui T, et al. (2005) Therapeutic effects of rectal administration of basic fibroblast growth factor on experimental murine colitis. Gastroenterology 128: 975-986.","DOI":"10.1053\/j.gastro.2005.01.006"},{"key":"10.1124\/jpet.108.145128_bib28","doi-asserted-by":"crossref","unstructured":"Paul R, Zhang ZG, Eliceiri BP, Jiang Q, Boccia AD, Zhang RL, Chopp M, and Cheresh DA (2001) Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. Nat Med 7: 222-227.","DOI":"10.1038\/84675"},{"key":"10.1124\/jpet.108.145128_bib29","doi-asserted-by":"crossref","unstructured":"Rogers DF, Boschetto P, and Barnes PJ (1989) Plasma exudation: correlation between Evans blue dye and radiolabeled albumin in guinea pig airways in vivo. J Pharmacol Methods 21: 309-315.","DOI":"10.1016\/0160-5402(89)90068-5"},{"key":"10.1124\/jpet.108.145128_bib30","doi-asserted-by":"crossref","unstructured":"Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A, and Rubin R (2002) The burden of selected digestive diseases in the United States. Gastroenterology 122: 1500-1511.","DOI":"10.1053\/gast.2002.32978"},{"key":"10.1124\/jpet.108.145128_bib31","doi-asserted-by":"crossref","unstructured":"Sandor Z, Deng XM, Khomenko T, Tarnawski AS, and Szabo S (2006) Altered angiogenic balance in ulcerative colitis: a key to impaired healing. Biochem Biophys Res Commun 350: 147-150.","DOI":"10.1016\/j.bbrc.2006.09.021"},{"key":"10.1124\/jpet.108.145128_bib32","doi-asserted-by":"crossref","unstructured":"Satoh H, Sato F, Takami K, and Szabo S (1997) New ulcerative colitis model induced by SH blockers in rats and the effects of antiinflammatory drugs on the colitis. Jpn J Pharmacol 73: 299-309.","DOI":"10.1254\/jjp.73.299"},{"key":"10.1124\/jpet.108.145128_bib33","doi-asserted-by":"crossref","unstructured":"Scheppke L, Aguilar E, Gariano RF, Jacobson R, Hood J, Doukas J, Cao J, Noronha G, Yee S, Weis S, et al. (2008) Retinal vascular permeability suppression by topical application of a novel VEGFR2\/Src kinase inhibitor in mice and rabbits. J Clin Invest 18: 2337-2346.","DOI":"10.1172\/JCI33361"},{"key":"10.1124\/jpet.108.145128_bib34","unstructured":"Senger DR, Perruzzi CA, Feder J, and Dvorak HF (1986) A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46: 5629-5632."},{"key":"10.1124\/jpet.108.145128_bib35","doi-asserted-by":"crossref","unstructured":"Spalinger J, Patriquin H, Miron MC, Marx G, Herzog D, Dubois J, Dubinsky M, and Seidman EG (2000) Doppler US in patients with Crohn disease: vessel density in the diseased bowel reflects disease activity. Radiology 217: 787-791.","DOI":"10.1148\/radiology.217.3.r00dc19787"},{"key":"10.1124\/jpet.108.145128_bib36","doi-asserted-by":"crossref","unstructured":"Szabo S, Sandor Z, Vincze A, Gombos Z, Mohiuddin A, and Viravathana T (1998) Radiation-induced enterocolitis: basic and applied science. Eur J Surg Suppl 582: 85-89.","DOI":"10.1080\/11024159850191508"},{"key":"10.1124\/jpet.108.145128_bib37","doi-asserted-by":"crossref","unstructured":"Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, and McDonald DM (1999) Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286: 2511-2514.","DOI":"10.1126\/science.286.5449.2511"},{"key":"10.1124\/jpet.108.145128_bib38","doi-asserted-by":"crossref","unstructured":"Tsiolakidou G, Koutroubakis IE, Tzardi M, and Kouroumalis EA (2008) Increased expression of VEGF and CD146 in patients with inflammatory bowel disease. Dig Liver Dis 40: 673-679.","DOI":"10.1016\/j.dld.2008.02.010"},{"key":"10.1124\/jpet.108.145128_bib39","doi-asserted-by":"crossref","unstructured":"Weis S, Shintani S, Weber A, Kirchmair R, Wood M, Cravens A, McSharry H, Iwakura A, Yoon YS, Himes N, et al. (2004) Src blockade stabilizes a Flk\/cadherin complex, reducing edema and tissue injury following myocardial infarction. J Clin Invest 113: 885-894.","DOI":"10.1172\/JCI200420702"},{"key":"10.1124\/jpet.108.145128_bib40","doi-asserted-by":"crossref","unstructured":"Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B, Kleinschek MA, Owyang A, Mattson J, Blumenschein W, et al. (2006) IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116: 1310-1316.","DOI":"10.1172\/JCI21404"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652434827X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652434827X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.108.145128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:52:06Z","timestamp":1740005526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652434827X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S002235652434827X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.108.145128","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutralizing Anti-Vascular Endothelial Growth Factor (VEGF) Antibody Reduces Severity of Experimental Ulcerative Colitis in Rats: Direct Evidence for the Pathogenic Role of VEGF","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.108.145128","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright","name":"copyright","label":"Copyright"}]}}